Home/News/Batch testing passed
NSG / News archive — 6 August 2026

Why our gels never say "shake well."

From the archive — on 6 August 2026, AniVatio reported a passed round of independent batch testing — every production batch verified to deliver active inclusion within ±5% of the declared label value per 1ml serving — and announced the expansion of its global patent portfolio into new health categories.

Published 2026-08-06 · Updated 2026-09-02

Part of our news archive — a retrospective record of NSG and AniVatio milestones, each dated to the day it was announced. AniVatio is NSG's consumer companion-animal brand, with all nutrition technology developed in-house by the group.

Some announcements are launches; this one was a lab report. On 6 August 2026, Lisa Hilton — writing from her self-declared happy place, the lab — shared that AniVatio's latest round of independent batch testing had passed: verification that the active ingredient content in the gels sits within ±5% of the declared label value, in every single 1ml serving.

A mixing unit running a 500 RPM, 60° suspension trial on the NSG formulation bench, lab technicians working behind On the formulation bench — suspension work of the kind that keeps a dose identical from the first serving of a bottle to the last

The "shake well" tell

The announcement put plain words on a detail owners rarely notice: AniVatio's flavoured gels never carry "Shake Well Before Use" — because the patented suspension technology holds actives evenly distributed without settling. In a liquid that separates, the dose depends on how hard you shook it; in a stable suspension, serving one and serving sixty carry the same inclusion. Every production batch is independently tested against that ±5% standard — the same evidence-matched-to-claim discipline set out across our formulation and manufacturing pages, and the reason a consistent daily serving can be promised at all, whether the gel is given from the syringe or mixed into food.

The patent map widens

The same announcement sketched where the technology goes next, with the group expanding its global patent portfolio into new health categories:

It also confirmed something usually kept quiet: the group manufactures its patented technology for a number of leading global pet brands — the same platform offered through our white-label and co-development programmes.

Frequently asked questions

What does the ±5% testing verify?

That the active ingredient inclusion in each production batch sits within ±5% of the value declared on the label, per 1ml serving — verified by independent testing of every batch rather than in-house checks alone.

Why don't AniVatio gels say "Shake Well Before Use"?

Because the patented suspension technology holds actives evenly distributed without settling, each serving carries a consistent dose without shaking — which is what the batch testing independently verifies.

Which categories is the patent portfolio expanding into?

Calming, dental health, renal health and multivitamins, alongside continued development of the existing gut health and joint health technologies — as announced on 6 August 2026.

Start a conversation with the science team.

Tell us what you are working on — a product idea, a herd problem, a brand you want built. We will route it to the right scientist or partner lead.

Send the team an enquiry
Chat on WhatsApp